BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9187910)

  • 1. T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activated.
    Reyes E; Carballido J; Prieto A; Molto L; Manzano L; Alvarez-Mon M
    Eur Urol; 1997; 31(4):472-7. PubMed ID: 9187910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
    Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M
    Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intracavitary interferon-alpha-2b in the prophylactic treatment of patients with superficial bladder cancer.
    Moltó L; Alvarez-Mon M; Carballido J; Olivier C; Gimeno F; Manzano L
    Cancer; 1995 Jun; 75(11):2720-6. PubMed ID: 7743476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomas.
    Cresswell J; Robertson H; Neal DE; Griffiths TR; Kirby JA
    Clin Exp Immunol; 2001 Dec; 126(3):397-402. PubMed ID: 11737053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymostimulin enhances the natural cytotoxic activity of patients with transitional cell carcinoma of the bladder.
    Moltó LM; Carballido JA; Manzano L; Olivier C; Lapuerta M; Alvarez-Mon M
    Int J Immunopharmacol; 1993 Apr; 15(3):335-41. PubMed ID: 8505146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells.
    Hermann GG; Petersen KR; Steven K; Zeuthen J
    J Clin Immunol; 1990 Nov; 10(6):311-20. PubMed ID: 1707414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of superficial transitional cell carcinoma of bladder.
    Agarwal A; Verma S; Burra U; Murthy NS; Mohanty NK; Saxena S
    Cancer Immunol Immunother; 2006 Jun; 55(6):734-43. PubMed ID: 16283306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonality of tumor-infiltrating lymphocytes in human urinary bladder carcinoma.
    Velotti F; Chopin D; Gil-Diez S; Maille P; Abbou CC; Kourilsky P; Even J
    J Immunother; 1997 Nov; 20(6):470-8. PubMed ID: 9409453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keyhole limpet hemocyanine can enhance the natural killer activity of patients with transitional cell carcinoma of the bladder.
    Moltó LM; Carballido J; Jurincic C; Lapeña P; Manzano L; Salmerón I; Klippel KF; Alvarez-Mon M
    Eur Urol; 1991; 19(1):74-8. PubMed ID: 2007423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma.
    Kastelan Z; Lukac J; Derezić D; Pasini J; Kusić Z; Sosić H; Kastelan M
    Anticancer Res; 2003; 23(6D):5185-9. PubMed ID: 14981987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance and prognostic value of morphology of regional lymph nodes and of peritumoral lymphocyte infiltration in bladder cancer.
    Martínez-Piñeiro JA; Gamallo C; Isorna S; Marrón C; Ortas J; Contreras F
    Eur Urol; 1979; 5(1):7-13. PubMed ID: 311735
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
    Troye M; Vilien M; Pape GR; Perlmann P
    Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effect of interferon-alpha 2b on natural killer cells and T lymphocytes from patients with transitional cell carcinoma of the bladder.
    Alvarez-Mon M; Moltó LM; Manzano L; Olivier C; Carballido JA
    Anticancer Drugs; 1992 May; 3 Suppl 1():5-8. PubMed ID: 1611117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell activity and response to phytohaemagglutinin compared with the histological diagnosis of patients with transitional cell carcinoma of the bladder.
    Britten V; Rees RC; Clegg A; Smith GT; Potter CW; Fox M; Williams JL
    Br J Urol; 1982 Jun; 54(3):261-6. PubMed ID: 7104588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC nonrestricted cytotoxic T cell clones with selective specificity from patients with transitional cell carcinoma (TCC) of the urinary bladder.
    Hansson Y; Vargas-Cortes M; Paulie S; Perlmann P
    Cancer Immunol Immunother; 1988; 27(3):205-12. PubMed ID: 3263206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific activation of human peripheral blood gamma/delta + lymphocytes by sonicated antigens of Mycobacterium tuberculosis: role in vitro in killing human bladder carcinoma cell lines.
    Wang MH; Chen YQ; Gercken J; Ernst M; Böhle A; Flad HD; Ulmer AJ
    Scand J Immunol; 1993 Sep; 38(3):239-46. PubMed ID: 8356400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I and class II HLA antigen expression by transitional cell carcinoma of the bladder: correlation with T-cell infiltration and BCG treatment.
    Stefanini GF; Bercovich E; Mazzeo V; Grigioni WF; Emili E; D'Errico A; Lo Cigno M; Tamagnini N; Mazzetti M
    J Urol; 1989 Jun; 141(6):1449-53. PubMed ID: 2657113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
    Shabtai M; Ye H; Frischer Z; Martin J; Waltzer WC; Malinowski K
    J Urol; 2002 Nov; 168(5):2216-9. PubMed ID: 12394762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus Calmette-Guérin sensitises fresh transitional carcinoma cells and T24 cell line to non-MHC-restricted cytotoxicity in vitro.
    Kaasinen ES; Kalliomäki PH; Alfthan OS; Timonen TT
    Br J Urol; 1993 Dec; 72(6):897-906. PubMed ID: 8306153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.